Tag: Mark Rothera
Gene therapy company Orchard Therapeutics raises $150m in new funding
Orchard Therapeutics, a UK and US based gene therapy company, has secured $150 million of new capital through a Series C funding round, towards advancing ... Read More
GSK offloads rare disease gene therapy drugs to Orchard Therapeutics
Pharma acquisition news : British drug company GlaxoSmithKline (GSK) has agreed to transfer its rare disease gene therapy drugs to Orchard Therapeutics for an equity ... Read More